Shionogi, Inc.

2011 News Archive

12/07/2011	Shionogi & Co., LTD. and Shionogi Inc. announce a favorable decision in Fortamet® preliminary injunction proceedings
07/18/2011	Shionogi Inc. Signs Agreement to Expand its Portfolio with Acquisition of Nine Marketed Products From Victory Pharma, Inc.
05/09/2011	Shionogi Inc. Announces Publication of Data in Pediatrics Demonstrating Efficacy of Kapvay™ (clonidine hydrochloride) Extended Release Tablets as Add-On Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
04/07/2011	Shionogi announces commercial availability of CUVPOSA™ (glycopyrrolate) oral solution for pediatric chronic severe drooling associated with neurologic conditions
04/04/2011	Shionogi Announces New US Leadership
02/03/2011	Shionogi-ViiV Healthcare Starts Phase III Trial for “572-Trii” Fixed-Dose Combination HIV Therapy
01/10/2011	Shionogi Inc. Announces Commercial Availability of KAPVAY™ (clonidine hydrochloride) Extended-Release Tablets for the Treatment of ADHD